New aspects in thyroid cancer treatment. Highlights of the ASCO Annual Meeting 2018

被引：0
|
作者：
Moeckelmann, N. [1 ]
Muenscher, A. [1 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, UCCH, Klin & Poliklin Hals Nasen & Ohrenheilkunde, Kopf Hals Tumorzentrum,Kopf Hals Chirurg, Martinistr 52, D-20246 Hamburg, Germany
来源：
HNO | 2018年 / 66卷 / 12期
关键词：
Thyroid cancer; Radioiodine-refractory; Anaplastic; Tyrosine kinase inhibitor; Immunotherapy;
D O I：
10.1007/s00106-018-0589-z
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
Whereas surgical treatment of thyroid carcinoma plays an important role especially in the early stages, a multimodal approach is pursued in the palliative setting, which, in addition to classical chemotherapy primarily involves treatment with tyrosine kinase inhibitors. An analysis of clinical trials and studies presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2018 is presented. In particular, studies on the treatment of radioiodine-refractory differentiated thyroid cancer, anaplastic thyroid cancer and immunotherapy were selected and analyzed. Clinically and preclinically relevant studies are presented and critically interpreted in this review.
引用
收藏
页码：896 / 900
页数：5
相关论文
共 50 条
  • [41] Update on HPV-associated head and neck cancer-highlights from the 2019 ASCO Annual Meeting
    Tribius, S.
    Wurdemann, N.
    Laban, S.
    Hoffmann, T. K.
    Sharma, S. J.
    Klussmann, J. P.
    [J]. HNO, 2019, 67 (12) : 912 - 917
  • [42] Maligne Speicheldrüsentumoren – Highlights der ASCO-Jahrestagung 2019Salivary gland malignancies—highlights of the 2019 ASCO Annual Meeting
    J. Doescher
    P. J. Schuler
    J. Greve
    M. F. Meyer
    S. Weissinger
    T. K. Hoffmann
    S. Laban
    [J]. HNO, 2019, 67 : 931 - 934
  • [43] Immunotherapeutic studies of head and neck tumors. Highlights of the 2016 ASCO Annual Meeting
    Busch, C-J.
    Laban, S.
    Knecht, R.
    Hoffmann, T. K.
    [J]. HNO, 2016, 64 (10) : 708 - 716
  • [44] Highlights From the Annual Meeting of the American Epilepsy Society 2018
    Jobst, Barbara C.
    Ben-Menachem, Elinor
    Chapman, Kevin E.
    Fu, Aradia
    Goldman, Alica
    Hirsch, Lawrence J.
    Jehi, Lara E.
    Kossoff, Eric H.
    Plueger, Madona
    Rho, Jong M.
    Schevon, Catherine A.
    Shinnar, Shlomo
    Sperling, Michael R.
    Simeone, Timothy A.
    Wagner, Janelle L.
    Lado, Fred
    [J]. EPILEPSY CURRENTS, 2019, 19 (03) : 152 - 158
  • [45] Ovarian cancer-ASCO annual meeting update 2021
    Schoche, Johannes
    Strasser-Weippl, Kathrin
    [J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2021, 14 (04) : 342 - 346
  • [46] Immuno-, radio-, and chemotherapeutic studies in head and neck cancer. Highlights of the ASCO Annual Meeting 2017
    Schuler, P. J.
    von Witzleben, A.
    Doescher, J.
    Wollenberg, B.
    Dietz, A.
    Hoffmann, T. K.
    [J]. HNO, 2018, 66 (03) : 212 - 218
  • [47] Highlights in Colorectal Cancer From the 2018 American Society of Clinical Oncology Annual Meeting Abstracts
    不详
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (09) : 7 - 11
  • [48] Preclinical Research in Treatment of Pancreatic Cancer Highlights from the "2013 ASCO Annual Meeting". Chicago, IL, USA; May 30 - June 4, 2013
    Skoura, Evangelia
    Syrigos, Konstantinos N.
    Saif, Muhammad Wasif
    [J]. JOURNAL OF THE PANCREAS, 2013, 14 (04): : 384 - 387
  • [49] Highlights From the ASCO Annual Meeting-NewApproaches to Cancers of the Blood, Brain, Lung, and More
    Suran, Melissa
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (02): : 104 - 106
  • [50] ASCO GU 2018: New Treatment Options for Prostate Cancer Patients
    Emrich, Gerhard
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (05) : 327 - 328
12345